Provided by Tiger Trade Technology Pte. Ltd.

ZAI LAB

20.340
-0.360-1.74%
Volume:8.57M
Turnover:171.97M
Market Cap:23.15B
PE:-16.19
High:20.540
Open:20.540
Low:19.670
Close:20.700
52wk High:27.360
52wk Low:12.310
Shares:1.14B
HK Float Shares:1.14B
Volume Ratio:0.67
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.257
ROE:-26.91%
ROA:-14.75%
PB:4.86
PE(LYR):-16.19
PS:6.57

Loading ...

Movement Alert|Zai Lab Rises 5.57% in Regular Trading, Schizophrenia Drug Launch and Cervical Cancer Drug Approval Drive Dual Catalysts

Market Focus
·
Jun 10

Zai Lab Shares Surge on Dual Drug Approvals and Market Launches

Stock News
·
Jun 10

Zai Lab says China NMPA approves TIVDAK for recurrent or metastatic cervical cancer

Reuters
·
Jun 09

Zai Lab Receives China Nmpa Approval of Tivdak® (Tisotumab Vedotin for Injection) for the Treatment of Adult Patients With Recurrent or Metastatic Cervical Cancer

THOMSON REUTERS
·
Jun 09

Zai Lab files initial beneficial ownership statement for Operating Partner Wang Yizhe

Reuters
·
Jun 09

Movement Alert|Zai Lab Falls 5.05% in Regular Trading, Fundamentals Under Pressure Amid Broad Biotech Sector Weakness

Market Focus
·
Jun 05

HK Movers | Biotech Stocks Jump. Asymchem up Nearly 7%; SKB Bio up About 6%; Hengrui Pharma, Pharmaron, InnoGen up over 4%; Wuxi Apptec up 3%; Laekna, Joinn, Remegen up over 2%

Tiger Newspress
·
Jun 05

Zai Lab: No Change in Share Count for May 2026, USD 0.41 Million Raised from Option Exercises

Bulletin Express
·
Jun 04

Zai Lab Ltd Announces Grant of 5,000 Restricted Share Units

Stock News
·
Jun 03

Zai Lab grants 500 restricted share units under 2024 equity incentive plan

Reuters
·
Jun 03

Movement Alert|Zai Lab Rises 5.51% in Regular Trading, ASCO Annual Meeting Opening Catalyzes Biotech Sector Rebound

Market Focus
·
May 29

Movement Alert|Zai Lab Falls 5.03% in Regular Trading, President Dismissal Compounds Core Product Revenue Decline

Market Focus
·
May 28

Zai Lab Announces Leadership Change: President and COO to Step Down

Stock News
·
May 22

Zai Lab: President & COO Josh Smiley Steps Down; CEO Samantha Du Takes Over Operational Duties

Bulletin Express
·
May 22

Zai Lab Announces Changes to Senior Leadership Team

THOMSON REUTERS
·
May 22

Zai Lab COO Josh Smiley exits; CEO Samantha Du assumes responsibilities

Reuters
·
May 22

Johnson & Johnson says nipocalimab approved in China

Reuters
·
May 21

Zai Lab CEO Du Ying disposes 100,000 shares for $1.99 million

Reuters
·
May 20

BRIEF-Goldman Sachs Group's Long Position In Zai Lab Decreases On May 14, HKEX Filing Shows

Reuters
·
May 19

Goldman Sachs Group's Long Position in Zai Lab Ltd Decreases to 6.67% on May 14 From 7.53% - HKEX

THOMSON REUTERS
·
May 19